Gainers
- iRhythm Technologies IRTC stock rose 21.6% to $143.58 during Friday's pre-market session. The company's market cap stands at $4.2 billion. As per the news, the Q1 earnings report came out yesterday.
- Cue Biopharma CUE shares moved upwards by 14.99% to $4.6. The market value of their outstanding shares is at $162.7 million.
- Sensus Healthcare SRTS shares moved upwards by 11.73% to $8.0. The company's market cap stands at $133.4 million. As per the press release, Q1 earnings came out yesterday.
- LogicBio Therapeutics LOGC stock rose 10.85% to $0.61. The market value of their outstanding shares is at $20.1 million.
- AcelRx Pharmaceuticals ACRX stock increased by 8.77% to $0.23. The company's market cap stands at $33.5 million.
- ChemoCentryx CCXI shares increased by 8.69% to $17.0. The market value of their outstanding shares is at $1.2 billion. The company's, Q1 earnings came out yesterday.
Losers
- Endo International ENDP shares fell 38.1% to $1.25 during Friday's pre-market session. The company's market cap stands at $293.8 million. As per the press release, Q1 earnings came out yesterday.
- T2 Biosystems TTOO stock fell 18.71% to $0.31. The market value of their outstanding shares is at $53.5 million. As per the news, the Q1 earnings report came out yesterday.
- Kintara Therapeutics KTRA shares decreased by 10.48% to $0.19. The market value of their outstanding shares is at $12.4 million.
- Sonoma Pharmaceuticals SNOA shares decreased by 10.32% to $3.13. The market value of their outstanding shares is at $9.6 million.
- Monopar Therapeutics MNPR stock declined by 9.1% to $2.0. The market value of their outstanding shares is at $25.2 million.
- Vanda Pharmaceuticals VNDA stock fell 8.17% to $9.0. The market value of their outstanding shares is at $508.4 million. The company's, Q1 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in